Atlas Trials

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Clinical trial NCT01646177 · COMPLETED

Trial details

NCT number
NCT01646177
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2012-07-28
Primary completion
2014-05-22
Enrollment
1346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.